Konrad Aumann

9PUBLICATIONS
90CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsCellular immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 21, 2024
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.

Shifa Khaja Saleem, Sarah Decker, Sandra Kissel

|Feb 21, 2024
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease.

Marie Czech, Sophia Schneider, Nina Peltokangas

|Dec 21, 2022
Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling.

Tamina Rückert, Geoffroy Andrieux, Melanie Boerries

|Apr 03, 2021
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.

Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess

|Aug 09, 2020
Critical assessment of staining properties of a new visualization technology: a novel, rapid and powerful immunohistochemical detection approach.

M Seidl, B Weinhold, L Jacobsen

|Dec 18, 2019
Optimized Xenograft Protocol for Chronic Lymphocytic Leukemia Results in High Engraftment Efficiency for All CLL Subgroups.

Sarah Decker, Anabel Zwick, Shifa Khaja Saleem

Pageof 2

Frequent Collaborators

3 joint publications

Lukas M Braun

3 joint publications

Melanie Boerries

3 joint publications

Robert Zeiser

3 joint publications

Annette Schmitt-Graeff